D\u00fcssel\u00addorf \u2014 D\u00fcssel\u00addorf-based MedTech company CUREo\u00adsity announ\u00adced that it has recei\u00adved 3.8 million euros in a finan\u00adcing round from exis\u00adting and new inves\u00adtors. In addi\u00adtion to other new co-inves\u00adtors, the exis\u00adting inves\u00adtor Tech\u00adVi\u00adsion Fund (TVF) and the Belgian family office Noma\u00adin\u00advest also participated.<\/p>\n
TVF, specia\u00adli\u00adzing in invest\u00adments in medi\u00adcal tech\u00adno\u00adlogy compa\u00adnies, has been support\u00ading CUREo\u00adsity in its virtual reality therapy through gami\u00adfi\u00adca\u00adtion since 2021.<\/p>\n
The finan\u00adcing round was also supported by the law firms ADVANT Beiten<\/strong> and Forvis Mazars<\/strong>. \u2014 The latest finan\u00adcing round will enable the German company to further advance its inno\u00adva\u00adtive solu\u00adti\u00adons and expand its market presence.<\/p>\n Caesar van Heynin\u00adgen, CEO of CUREo\u00adsity<\/strong>, says: \u201cThe current successful course \u2014 consis\u00adting of scaling the markets and high-quality updates to our therapy soft\u00adware \u2014 will be streng\u00adthe\u00adned by this finan\u00adcing. We plan to invest heavily in commer\u00adcial expan\u00adsion and inte\u00adgrate tomor\u00adro\u00adw\u2019s tech\u00adno\u00adlo\u00adgi\u00adcal possi\u00adbi\u00adli\u00adties into our product road\u00admap today. With this finan\u00adcing round, we can ensure finan\u00adcial inde\u00adpen\u00addence and sustainable busi\u00adness operations.\u201d<\/p>\n The idea behind CUREosity The two co-foun\u00adders of CUREo\u00adsity \u2014 Stefan Arand and Marco Faul\u00adham\u00admer \u2014 expe\u00adri\u00aden\u00adced simi\u00adlar fates and chal\u00adlenges, which led them to the decis\u00adion to deve\u00adlop a new form of therapy that combi\u00adnes their thera\u00adpeu\u00adtic expe\u00adri\u00adence and know\u00adledge with current tech\u00adno\u00adlo\u00adgies and neuro\u00adsci\u00aden\u00adti\u00adfic findings. Thanks to many years of expe\u00adri\u00adence in 3D visua\u00adliza\u00adtion and the crea\u00adtion of appli\u00adca\u00adtion concepts in the IT and science sector, the foun\u00adders have sound tech\u00adni\u00adcal know-how.<\/p>\n The combi\u00adna\u00adtion of tech\u00adni\u00adcal skills, exper\u00adtise in 3D visua\u00adliza\u00adtion, expe\u00adri\u00adence with virtual reality and perso\u00adnal moti\u00adva\u00adtion due to medi\u00adcal condi\u00adti\u00adons led to the foun\u00adding of CUREo\u00adsity and the idea for CUREO.<\/p>\n CUREo\u00adsity: Virtual reality therapy through gamification The advan\u00adta\u00adges include evidence-based thera\u00adpeu\u00adtic success, sustained relief for staff, increased pati\u00adent moti\u00adva\u00adtion, a wide range of appli\u00adca\u00adti\u00adons and simple and intui\u00adtive opera\u00adtion. The 50 trai\u00adning sessi\u00adons in 7 modu\u00adles can be used in physio\u00adthe\u00adrapy, occu\u00adpa\u00adtio\u00adnal therapy and neuro\u00adpsy\u00adcho\u00adlogy. Curr\u00adently, the soft\u00adware is used in 24 count\u00adries worldwide. About Tech\u00adVi\u00adsion Fund (TVF)<\/strong><\/p>\n Tech\u00adVi\u00adsion Fund (TVF) is a seed capi\u00adtal firm focu\u00adsed on inves\u00adt\u00ading in tech\u00adno\u00adlogy compa\u00adnies that have the poten\u00adtial to trans\u00adform key indus\u00adtries. The company\u2019s stra\u00adtegy is based on early enga\u00adge\u00adment and prima\u00adrily targets seed-stage invest\u00adments, with occa\u00adsio\u00adnal initial invest\u00adments in Series A. The company\u2019s focus spans SaaS\/software, IoT, digi\u00adtal solu\u00adti\u00adons, medtech, biotech, new mate\u00adri\u00adals and greentech\/cleantech.<\/p>\n Bj\u00f6rn Lang, Part\u00adner at TVF<\/strong>, says: \u201cCUREOSITY solves the problem of the shortage of skil\u00adled workers in the therapy sector. Smart solu\u00adti\u00adons such as CUREO are highly rele\u00advant to society, parti\u00adcu\u00adlarly due to demo\u00adgra\u00adphic change. We look forward to parti\u00adci\u00adpa\u00adting in the solu\u00adti\u00adons and succes\u00adses in the future.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":" D\u00fcssel\u00addorf \u2014 D\u00fcssel\u00ad\u00addorf-based MedTech company CUREo\u00adsity announ\u00adced that it has recei\u00adved 3.8 million euros in a finan\u00adcing round from exis\u00adting and new inves\u00adtors. In addi\u00adtion to other new co-inves\u00ad\u00adtors, the exis\u00adting inves\u00adtor Tech\u00adVi\u00adsion Fund (TVF) and the Belgian family office Noma\u00adin\u00advest also parti\u00adci\u00adpa\u00adted. TVF, specia\u00adli\u00adzing in invest\u00adments in medi\u00adcal tech\u00adno\u00adlogy compa\u00adnies, has been support\u00ading CUREosity [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":51754,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1369,1373],"tags":[],"class_list":["post-51757","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-investors","category-venture-capital-en"],"yoast_head":"\n
\n<\/strong>
\nCUREO is based on the perso\u00adnal expe\u00adri\u00aden\u00adces of the foun\u00adders \u2014 Thomas Saur, Stefan Arand and Marco Faul\u00adham\u00admer: After a car acci\u00addent in 2000, Thomas Saur\u2019s young son suffe\u00adred from para\u00adple\u00adgia. In the search for the best possi\u00adble care and reha\u00adbi\u00adli\u00adta\u00adtion, exis\u00adting methods did not bring the desi\u00adred success.<\/p>\n
\n<\/strong>
\nUnder the leader\u00adship of Caesar van Heynin\u00adgen, CUREo\u00adsity became known for its virtual reality therapy system called CUREO for clinics and practices.<\/p>\n
\nwww.cureosity.com<\/p>\n